CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −9,467 | 2,468 | ||
| 2023-01-04 | Doerfler Douglas President and CEO | Exercise or conversion | +9,153 | $0.04 | $366 | 342,350 |
| 2023-01-04 | Doerfler Douglas President and CEO | Sale | −9,153 | $5.07 | $46K | 333,197 |
| 2023-01-04 | Doerfler Douglas President and CEO | Exercise or conversion · Employee Stock Option (right to buy) | −9,153 | 425,314 | ||
| 2023-01-04 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +9,153 | $0.98 | $9K | 9,153 |
| 2023-01-04 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −9,153 | $5.07 | $46K | 0 |
| 2023-01-04 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −9,153 | 11,935 | ||
| 2023-01-03 | Doerfler Douglas President and CEO | Exercise or conversion | +10,613 | $0.04 | $425 | 343,810 |
| 2023-01-03 | Doerfler Douglas President and CEO | Sale | −10,613 | $5.13 | $54K | 333,197 |
| 2023-01-03 | Doerfler Douglas President and CEO | Exercise or conversion · Employee Stock Option (right to buy) | −10,613 | 434,467 | ||
| 2023-01-03 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +10,513 | $0.98 | $10K | 10,513 |
| 2023-01-03 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −10,513 | $5.13 | $54K | 0 |
| 2023-01-03 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −10,513 | 21,088 | ||
| 2022-12-05 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +14,133 | $1.08 | $15K | 14,133 |
| 2022-12-05 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −14,133 | $5.59 | $79K | 0 |
| 2022-12-05 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −14,133 | 31,601 | ||
| 2022-12-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +15,000 | $1.08 | $16K | 15,000 |
| 2022-12-02 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −15,000 | $6.02 | $90K | 0 |
| 2022-12-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −15,000 | 45,734 | ||
| 2022-11-30 | BALTHROP PATRICK J Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 16 of 21 · 411 trades